Compounds > 17 alpha-hydroxyprogesterone caproate
Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and hrp 112

17 alpha-hydroxyprogesterone caproate has been researched along with hrp 112 in 3 studies

Compound Research Comparison

Studies
(17 alpha-hydroxyprogesterone caproate)		Trials
(17 alpha-hydroxyprogesterone caproate)		Recent Studies (post-2010)
(17 alpha-hydroxyprogesterone caproate)		Studies
(hrp 112)		Trials
(hrp 112)		Recent Studies (post-2010) (hrp 112)
5178825167321

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sang, GW1
Koetsawang, S1

Reviews

3 review(s) available for 17 alpha-hydroxyprogesterone caproate and hrp 112

ArticleYear
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Contraception, 1994, Volume: 49, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone

1994
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Contraception, 1994, Volume: 49, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic

1994
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bulletin of the World Health Organization, 1993, Volume: 71, Issue:6

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization

1993